#AHA20

Muthu Vaduganathan

mvaduganathan

Timely discussion. Do recurrent events always provide greater power than time-to-first events?In many cases, adapting to recurrent events is favorable as w #SOLOISTWHF #AHA20 @DLBHATTMDHowever, despite ↓ events, time-to-first may

Dr. Martha Gulati “Masks are the New Black”

DrMarthaGulati

Wonderful talk at #AHA10 @MarilynCipolla on #preeclampsia and the Brain #neuroobstetrics #cardioobstetrics @uvmvermont @MaryCushmanMD Preeclampsia is vascular disorderPreeclampsia defined below @acog Once you have PE, greater events, HTN,

fipco

fipco

How to explain positive results of REDUCE-IT and neutral outcome of STRENGTH? It’s possible that attained plasma EPA levels account for a good part of the difference. #AHA20 /1 Achieved

Enrique Santas

SantasEnrique

AFFIRM-AHF #AHA2020 Important trial showing benefit of iron carboxymaltose in acute #heartfailure Significant in HF It may change guidelines, highlighting the need to study and treat

Gmerice Hammond, MD MPH

GmericeH

Must see! @kejoynt shut it down in this session-> Transformation is Underway: An Update on AHA's Value in Healthcare Initiative. #AHA20. So real talk, @JoeBiden give her a call immediately.

Kevin C. Klatt, PhD, RD

KCKlatt

Tons of chatter about the new prescription omega 3 data coming forth. Lots of takes about the study designs, n3 formulations, differences across populations, variation in comparator groups. All important

By continuing to use the site, you are consenting to the use of cookies as explained in our Cookie Policy to improve your experience.